Role of Tc-99m pertechnetate for remnant scintigraphy, post-thyroidectomy, and serum thyroglobulin and antithyroglobulin antibody levels in the patients with differentiated thyroid cancer.
Annals of nuclear medicine, cilt.30, sa.1, ss.60-7, 2016 (SCI-Expanded)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 30 Sayı: 1
- Basım Tarihi: 2016
- Doi Numarası: 10.1007/s12149-015-1031-1
- Dergi Adı: Annals of nuclear medicine
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Sayfa Sayıları: ss.60-7
- Anahtar Kelimeler: Thyroid carcinoma, Technetium-99m pertechnetate, Iodine-131, Remnant ablation, FOLLOW-UP, I-131 SCANS, MBQ I-131, CARCINOMA, PAPILLARY, MANAGEMENT, ABLATION, THERAPY, DISEASE, TC-99M-PERTECHNETATE
- Akdeniz Üniversitesi Adresli: Evet
Özet
Aim Postoperative scanning may help to identify patients with differentiated thyroid cancer (DTC); however, low dose I-131 can lead to stunning and suboptimal response to ablative therapy. The aim of this retrospective study is to compare postablative I-131 scintigraphy with post-thyroidectomy Tc-99m pertechnetate scintigraphy, serum thyroglobulin (Tg) and antithyroglobulin antibody (TgAb) levels in patients with DTC.